Recently, the combination of urinary tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) has performed well in the prediction of moderate to severe AKI in a mixed population of critically ill patients [67]. The gene discussed is IGFBP7; the disease is acute kidney injury.